We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Report Sees Slowing Growth in PET Scans

By MedImaging International staff writers
Posted on 29 Aug 2012
The growth rate of PET (positron emission tomography) and PET/CT (computed tomography) medical imaging scans in the United States began to slow in 2011, with an estimated 1.85 million clinical PET patient exams performed in 2011, down from a double-digit growth rate reported in previous years, according to a new market research report by the IMV Medical Information Division.

“The estimated 1.85 million clinical PET patient studies performed in 2011 represent a 6% increase over IMV’s estimate of 1.74 million patient studies performed in 2010,” observed Lorna Young, senior director, market research at IMV (Des Plaines, IL, USA). “This represents a continued slowing in the annual growth rate for PET patient studies."

The current numbers compare to annual growth from 2008 to 2010 of about 7%, and to annual growth between 2005 and 2008 of 10%. Ms. Young noted that in 2011, most of the growth was from an increase in the number of sites providing PET services; the average procedure increase per site was only 0.6% when compared to 2010. These PET studies were performed in 2,210 hospital and nonhospital sites, using fixed or mobile PET/CT or PET scanners.

Oncology continues to drive the use of PET imaging procedures, as hospitals open cancer treatment centers and install PET/CT scanners to support their oncology services. The study found that about 94% of all PET studies in 2012 were for cancer, distributed between diagnosis (19%), staging (38%), treatment planning (13%), and follow up (30%). Neurology and cardiology applications make up the remaining 6% of procedures, divided evenly between the two.

Used for 96% of all PET procedures in 2011, fluorine-18 fluorodeoxyglucose (FDG) is still the mainstay of PET imaging. Rubidium-82, the next most frequently used radiopharmaceutical, was used for about 2% of all procedures, as problems with the supply of the radiopharmaceutical continued to limit its use for cardiac perfusion studies.

IMV is a leader in market research and online publishing for the medical imaging and clinical diagnostic instruments markets.

Related Links:
IMV


X-ray Diagnostic System
FDX Visionary-A
Biopsy Software
Affirm® Contrast
Medical Radiographic X-Ray Machine
TR30N HF
Ultrasound Table
Women’s Ultrasound EA Table

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.